UK Senior Vaccinologist: Futile Trying to Stop COVID Variants With Vaccines


Many people do not have the time or inclination to watch the 2 hour presentation by Dr. Robert Malone, the leading scientific research for global pandemics and originator of the technology behind mRNA vaccines {full video here}; so,  I will attempt to encapsulate.

As noted by Dr. Malone, the commonsense therapeutic approach should be the primary focus, not vaccination, for ongoing healthcare systems as the COVID-19 variants will continue to evolve.  Ultimately,  the natural immunity process will be of greater overall benefit than vaccinations which will require continual boosters to deal with the ever-evolving variants (a similar approach to dealing with reoccurring and evolving flu strains).   Dr. Malone provided support for his position with concurrence from the leading U.K. Vaccinologist in Great Britain, Sir Andrew Pollard (SHORT VIDEO):

In essence, both Dr. Andrew Pollard (Director of the U.K. Oxford Vaccine Group) and Dr. Malone state that variants of the COVID-19 virus will continue to spread throughout the population regardless of vaccine status; and the virus will continue to evolve into more infectious but less deadly or pathogenic strains.

There simply is no way to vaccinate the population and stop the spread of COVID variants, because the vaccinated will contract and spread the virus just like the non-vaccinated.  The vaccine approach should be targeted to the elderly and those most at risk.

[NOTE: – One aspect of the scientific concurrence between Dr. Malone and Dr. Pollard is to contemplate just how futile it is for the Australian government to continue their current lock-down approach.  Every time a single person contracts covid they lock-down the entire community, but there is no way to ever stop the virus completely.  The Australian government is trying to collect water in a sieve.]

Specific to the position of Dr. Malone – given the untested nature of the vaccine itself; no one knows the long-term side-effects; the benefit of the vaccine should be weighed against the individual’s current health status.  Elderly populations with lower immune responses should be the target for vaccination; they are the most at risk.  However, younger -less at risk- individuals will likely benefit more from therapeutic treatment after exposure *if* they experience any symptoms at all.

The problem is…. This commonsense approach is less favorable to the interests of the pharmaceutical industry and the healthcare systems that are controlled by the financial mechanisms inside the business of healthcare.  Big Pharma would obviously make less money from a smaller target population for vaccination; ergo the therapeutic approach is a threat to the preferred approach of those who operate the business model.  This is the overarching political battle.

The influence of the massive pharmaceutical corporations, inside the institutions of government controlled healthcare on a global basis, is massive.  This outlook is the origin of the vaccinate push and vaccine narrative as the *only* and *best* solution.   Anyone who raises a point, any point, in opposition to the mandated mass vaccine approach then becomes a target to be isolated, marginalized, ridiculed and removed.

Dr. Malone gave examples of how he is currently one of the targets and the level of institutional pressure upon everyone inside the healthcare system is massive.  Malone demonstrated how there is only one allowed and approved narrative that must be maintained; the hive mindset and eco-chamber that promotes the vaccines as the only acceptable course of treatment and mitigation.  He calls this the “Noble Lie.”

Dr. Malone contracted COVID personally in 2020, and battled through the virus with a long-term outcome of some lung damage, what he calls “long-COVID.”  Dr. Malone had a resting oxygen capacity of 95%, post COVID recovery, substantially less than before he experienced the virus.  Dr. Malone took the Moderna two-dose vaccine as an outcome of his current employment status, and in the hope it would assist with the side-effects of long-covid.

Malone and his wife need to travel as a condition of their professional obligations, and without a vaccine identification, he cannot visit countries to fulfill his contractual responsibilities and continue work.   However, Dr. Malone did experience side-effects from the Moderna-x2 vaccine and successfully took a 5-day course of Ivermectin to counteract the vaccine side-effects.  He reports this treatment course was successful.

In summary, both Dr. Robert Malone (USA) and Dr. Andrew Pollard (U.K.) feel that vaccinations should be prioritized to the elderly population, and various national health systems need to SHIFT and start focusing on therapeutic treatments for ongoing variants as the vaccine will only provide a limited amount of mortality mitigation.

Source